%PDF-1.3
%
1 0 obj
<>]/Pages 3 0 R/Type/Catalog/ViewerPreferences<>>>
endobj
2 0 obj
<>stream
uuid:ac236064-3763-8046-aea0-d1075c50a225
xmp.did:CED091E8C12468118C14AD3D6CFEAA51
adobe:docid:indd:685ecc7d-ac27-11dd-9f10-dc2ab5f72af0
proof:pdf
1
saved
xmp.iid:6BBB7AC68920681188C6EDA14BE6C517
2010-08-16T14:21:42-05:00
Adobe InDesign 7.0
/;/metadata
saved
xmp.iid:6CBB7AC68920681188C6EDA14BE6C517
2010-08-16T14:21:42-05:00
Adobe InDesign 7.0
/metadata
saved
xmp.iid:03801174072068118C14C000F966B46C
2010-08-16T11:26:18-05:00
Adobe InDesign 7.0
/;/metadata
saved
xmp.iid:06801174072068118C14C000F966B46C
2010-08-16T11:43:31-05:00
Adobe InDesign 7.0
/;/metadata
saved
xmp.iid:09801174072068118C14C000F966B46C
2010-08-16T11:56:49-05:00
Adobe InDesign 7.0
/;/metadata
saved
xmp.iid:DFDE13FB0A2068118C14E1031A213A58
2010-08-18T13:57:26-05:00
Adobe InDesign 7.0
/;/metadata
saved
xmp.iid:E0DE13FB0A2068118C14E1031A213A58
2010-08-18T14:07:30-05:00
Adobe InDesign 7.0
/;/metadata
saved
xmp.iid:F97F1174072068118C14D1066E6EF142
2010-08-18T15:27:09-05:00
Adobe InDesign 7.0
/;/metadata
saved
xmp.iid:78FFFE242B2068118C14A72764464A8E
2010-08-25T13:22:57-05:00
Adobe InDesign 7.0
/;/metadata
saved
xmp.iid:308B50CC402068118C14A72764464A8E
2010-08-25T13:31:09-05:00
Adobe InDesign 7.0
/;/metadata
saved
xmp.iid:F97F1174072068118C149770F857D616
2010-09-02T14:16:09-05:00
Adobe InDesign 7.0
/;/metadata
saved
xmp.iid:20B230F6372068118C14B69B1C4E14E2
2011-03-08T12:19:31-06:00
Adobe InDesign 7.0
/metadata
saved
xmp.iid:23B230F6372068118C14B69B1C4E14E2
2011-03-08T12:19:31-06:00
Adobe InDesign 7.0
/;/metadata
saved
xmp.iid:EC6B0CA61F2468118C14AD3D6CFEAA51
2011-07-07T10:26:38-05:00
Adobe InDesign 7.0
/metadata
saved
xmp.iid:CED091E8C12468118C14AD3D6CFEAA51
2011-07-07T10:26:38-05:00
Adobe InDesign 7.0
/;/metadata
saved
xmp.iid:D1D091E8C12468118C14AD3D6CFEAA51
2011-07-07T10:32:24-05:00
Adobe InDesign 7.0
/;/metadata
saved
xmp.iid:D3D091E8C12468118C14AD3D6CFEAA51
2011-07-07T10:47:37-05:00
Adobe InDesign 7.0
/;/metadata
saved
xmp.iid:D5D091E8C12468118C14AD3D6CFEAA51
2011-07-07T10:49:01-05:00
Adobe InDesign 7.0
/;/metadata
saved
xmp.iid:D6D091E8C12468118C14AD3D6CFEAA51
2011-07-07T10:53:42-05:00
Adobe InDesign 7.0
/;/metadata
saved
xmp.iid:9CF57471C72468118C14AD3D6CFEAA51
2011-07-07T11:06:15-05:00
Adobe InDesign 7.0
/;/metadata
saved
xmp.iid:9FF57471C72468118C14AD3D6CFEAA51
2011-07-07T11:18:46-05:00
Adobe InDesign 7.0
/;/metadata
saved
xmp.iid:C08E02E8E22468118C14AD3D6CFEAA51
2011-07-07T14:22:51-05:00
Adobe InDesign 7.0
/;/metadata
saved
xmp.iid:06801174072068118C14BBCC27DFF50B
2011-07-12T09:06:27-05:00
Adobe InDesign 7.0
/;/metadata
saved
xmp.iid:FAB1C0E2082068118A6DF7DA8DB1BB98
2011-07-13T10:03:28-05:00
Adobe InDesign 7.0
/;/metadata
saved
xmp.iid:198ECE03202068118A6DF7DA8DB1BB98
2011-07-13T13:06-05:00
Adobe InDesign 7.0
/;/metadata
saved
xmp.iid:84BADCC3322068118A6DF7DA8DB1BB98
2011-07-19T10:28:25-05:00
Adobe InDesign 7.0
/;/metadata
xmp.iid:EC6B0CA61F2468118C14AD3D6CFEAA51
xmp.did:23B230F6372068118C14B69B1C4E14E2
adobe:docid:indd:685ecc7d-ac27-11dd-9f10-dc2ab5f72af0
default
2012-03-20T13:56:21-05:00
2012-03-20T13:56:23-05:00
2012-03-20T13:56:23-05:00
Adobe InDesign CS5 (7.0.4)
1
JPEG
256
256
/9j/4AAQSkZJRgABAgEASABIAAD/7QAsUGhvdG9zaG9wIDMuMAA4QklNA+0AAAAAABAASAAAAAEA
AQBIAAAAAQAB/+4AE0Fkb2JlAGSAAAAAAQUAAgAD/9sAhAAMCAgICAgMCAgMEAsLCxAUDg0NDhQY
EhMTExIYFBIUFBQUEhQUGx4eHhsUJCcnJyckMjU1NTI7Ozs7Ozs7Ozs7AQ0LCxAOECIYGCIyKCEo
MjsyMjIyOzs7Ozs7Ozs7Ozs7Ozs7OztAQEBAQDtAQEBAQEBAQEBAQEBAQEBAQEBAQED/wAARCAEA
AMYDAREAAhEBAxEB/8QBQgAAAQUBAQEBAQEAAAAAAAAAAwABAgQFBgcICQoLAQABBQEBAQEBAQAA
AAAAAAABAAIDBAUGBwgJCgsQAAEEAQMCBAIFBwYIBQMMMwEAAhEDBCESMQVBUWETInGBMgYUkaGx
QiMkFVLBYjM0coLRQwclklPw4fFjczUWorKDJkSTVGRFwqN0NhfSVeJl8rOEw9N14/NGJ5SkhbSV
xNTk9KW1xdXl9VZmdoaWprbG1ub2N0dXZ3eHl6e3x9fn9xEAAgIBAgQEAwQFBgcHBgI7AQACEQMh
MRIEQVFhcSITBTKBkRShsUIjwVLR8DMkYuFygpJDUxVjczTxJQYWorKDByY1wtJEk1SjF2RFVTZ0
ZeLys4TD03Xj80aUpIW0lcTU5PSltcXV5fVWZnaGlqa2xtbm9ic3R1dnd4eXp7fH1+f3/9oADAMB
AAIRAxEAPwD0Xp/T8A4GMTjUkmmuT6bf3R5JKbH7P6f/ANxqf+22/wBySlfs/p//AHGp/wC22/3J
KV+z+n/9xqf+22/3JKV+z+n/APcan/ttv9ySlfs/p/8A3Gp/7bb/AHJKV+z+n/8Acan/ALbb/ckp
X7P6f/3Gp/7bb/ckpX7P6f8A9xqf+22/3JKV+z+n/wDcan/ttv8AckpX7P6f/wBxqf8Attv9ySlf
s/p//can/ttv9ySlfs/p/wD3Gp/7bb/ckpX7P6f/ANxqf+22/wBySlfs/p//AHGp/wC22/3JKa46
XifaXP8AstOwuaR7G8Bjge3iU69EVq2P2f0//uNT/wBtt/uTUq/Z/T/+41P/AG23+5JSv2f0/wD7
jU/9tt/uSUr9n9P/AO41P/bbf7klK/Z/T/8AuNT/ANtt/uSUr9n9P/7jU/8Abbf7klK/Z/T/APuN
T/223+5JSv2f0/8A7jU/9tt/uSU18np+ALsWManW4z+jb/orfJJTY6f/AMn43/E1/wDUhJSRzrDY
WMLQA0HUE8l38oeCKFRf++z/ADT/AOTS0VqqL/32f5p/8mlorVUX/vs/zT/5NLRWqov/AH2f5p/8
mlorVUX/AL7P80/+TS0VqqL/AN9n+af/ACaWitVRf++z/NP/AJNLRWq9Ti+tjzy5oJjzCB3SGaSl
JKUkpSSlJKUkpSSlJKUkpSSlJKUkpSSlJKa+T/PYn/HH/wA9XJKV0/8A5Pxv+Jr/AOpCSmZexlzi
9wbLWxJiYL0a0R1X9ej/AEjP84JUVWHP6l0npXVbW3ZVrtzG7Bst2iJnsfNKiqw0/wDmr0D/AEtv
/b5/vSoqsK/5q9A/0tv/AG+f70qKrCv+avQP9Lb/ANvn+9Kiqw7NBxcaivHrsbsqY2tsuBMNECT8
kqKrDP16P9Iz/OCVFVhVH8xX/Ub+RI7qGyRBKklKSUpJSklKSUpJSklKSUpJSklKSUpJSklNfJ/n
sT/jj/56uSUrp/8Ayfjf8TX/ANSElNhJSklKSU1OpYV2dQ2mnJtxHNeHGykw4gAjb8NUlOfX9X85
ljXnq+W4NIJaSIMdikp20lKSUpJSklKSUpJSklKSUpJSklKSUpJSklKSUpJSklOJlf8AO77TZ9j+
x+huPpepv3be26O6SkX/AGb/APdD/ppKbmT+1PseJ/NftDefH0t/pXfOElMT1anpuH02qyqy1+W1
lVbatuhFe4l297NICfDGZ34LJ5BGvFLi/WDpGTiV5hyaqG2MFmy6xjHtBDXe8btNHt+8IywzBqkR
ywIu0p6v0lszm442kNM2s0c4S0H3ckIe3PsV3uR7qPWekNALs7GAc5zQTczVzI3j6XLZ1S9qfYo9
yHdHj9e6Vk3WUsyKxssZUx7ns22uexlo9I7ju0eicMwNlDLEndiev9Ob9ra94ZZhvsrNT3MY6w1V
tuca97wCNruTHml7MtPFHux18Gw3qfT3Hb9ppDt7ay02MkWOEtYYd9I+CbwS7LuOPdDi9e6XmOIp
vZslrGPc9rQ9znWVhrQXbpmo9te0p0sM49ERyxl1bDM7Euxn5eNazIqrBJdS5rx7RuIlpiU0wINF
cJAiw5Lfrj0x9tVLasguua17YY0w19VV8mLOzbmz8+wlSnlpAMQ5iJLf6N1nF65iHMxG2MYHbC20
AOB2tePoucPovB5TMuI45UV+PIMgsN9Rr1JKUkpSSlJKUkpSSlJKUkpSSlJKUkpSSmvk/wA9if8A
HH/z1ckpwurZXSMPD6Pk9VqsuFLQ+mtjWPaXekG+9thHG6RHdPjkMQa6rZQEiL6PONyfqkzbsPU2
ljWNaR6Ghr9GH6zr+rs8vJS/ep9h/L/fYvu0e/8AL+QW9b6n7XMA6ltcCI/QmA5tzDEmf8O469/L
RL73Pw/l/vK+6w/l/LxUcj6qGk0B/VAxz3PcB9nO4vr9HWQfzJHjql96ld0FHlo1uWVOT9T6ra7t
nULH13nJl4oMvd6Zd8JNYOkeWmiR5qZFKHLQBtj1bO+rec7Iy6W5wy7Re5gf6QqD76m0ndBLtoDQ
UsfMmNDojJywlZ6t3o7Pqv1DqVVGOzMbk3ZAyt7hW1u+ttjyDtLnbTud4nzQPMzIrwpcOXgDf1d0
/UvpDrRc595Lbm5AG5sBzH3WgfQ4m4/gl96nSvu0LbHS/q3jdIq+zYt9xxnep6tVhad5eyqoElrW
/RbV+KbkzmZsjVOPCICgWuz6l9Lb6U3ZL/RcHDc9uuxtddYMVj6Damx38Zkpx5qfYIHLRDrdO6fj
dLwqsHEaG1UtDRoAXECC920NBceSVFOZnKyyQgIRoNlNXKSUpJSklKSUpJSklKSUpJSklKSUpJSk
lNfJ/nsT/jj/AOerklPOfWLJfj9L6YWv2bqx+c1swxn79diSnn/2lb/pv/Ba/wD3nSU6OF9Z6MXH
bTdiUZLwTNtlzQ4yZ7Y6Sk//ADvw/wDytxf+3m/+kElK/wCd+H/5W4v/AG83/wBIJKS431lqzL2Y
2N0vGsts0a0XNEwJ70DwSU6bL+sVuD6+h0scOHNyKwR91SSkv7Q+sP8A5UM/9i2f+k0lK/aH1h/8
qGf+xbP/AEmkpX7Q+sP/AJUM/wDYtn/pNJSv2h9Yf/Khn/sWz/0mkpdmf14vaH9Ka1pIDnfammB4
x6aSkf1jHVDXUemWGrYHvucLG1ANaG6uc9rhARAVbzf23rf/AJZ1f+x2P/5FKkW2q8f633NDqb7H
tc0Oa5uTUWkOmCCK47JUq0eF1L6xU9VGES/IvaXNNNtn6MkNLj7hU0aDzSpVuxd1T6z0V2W2dPoD
aWGx5Fsw0Angf1UqVbl/8+Oof9xKv/Bf/IJUlvY3X/rBl4j82jBodTXu3ONjmn2iT7XAFKkW18T6
29XzshmLjYdTrbJ2gusaNAXHVzAOAlSnRZn/AFn3fpMCgMaQHkWyQNCY+RSpVtjB+sOB1K/7PiNt
c8NLocwsECO7oHdKlN45MMdYa3hrJ3H26bZn87ySpVtXB65gdTe5mC43OrEuAgQD/WISpVpMm0b8
Szaf58t26TPp3N8Y5SpVudm9Oz+o9NwG4NrajXU0v3PsZMsbH8y5vh3QS0P+bX1g/wC5dX/b2V/6
USUr/m19YP8AuXV/29lf+lElKP1e65wLJPG77TfEgEExv4JIPwBSUsPq711ziG5dQI5ab8kkTxMW
JKX/AObX1g/7l1f9vZX/AKUSUxZ9XPrA5s/aa2/G3JBj5WeSSlz9W+vtEuzKgPE3ZP8A6USUv/za
+sH/AHLq/wC3sr/0okplX9Wuueo31stnp7hv2XZO7bOsTZykp1P+beJ/3IzP/Yiz+9JSv+beJ/3I
zP8A2Is/vSU3MwNcdjntYHV2D37S0zs+kHA6IjZB3eKd1DNFpr+z4xAdt3jFq2nWJ/nOElPV0F9e
K5rcukWtoAa9gYKQ4b4O390fFHpsjq8VSx4zGObRUx4sBFpr9rTu+mf1jjugl7LqNFebh3Y1mTUS
+uqTYW+mSHF0nbtMSPFHpsjru8jjdOZkZbsUsxqQ0uHrWMIrO3wPrnnsgl7djMZ1d2Ob/wBEf0Zb
LPo7Gtj6PgiR4IHm5XS+j4mL1B1/2enFFW70LmXB7jMt1aW6S0pV4J+rb6rSzLwMrH+01Q97SRcW
lh2it2u3ae3ikfJAec+r2IyzqLLXNpxfRIcC5uxzu0M/TPE/JD6Jeu249+PZRbkSyz1GPAc0S1xc
DqACiR4IHm0ui9Px8AXPEYz3v2gC/wBYOY36Lv0gMHU6JV4J+rYyS3ZiHfp9rPv0/wCG8oS6o6Nr
p/8Ayfjf8TX/ANSE1c2ElKSUskpC3ZZUz0S5m6HB0e4A+4zvHfzTtit3CTY/1N/qHaRGyBE6azEo
WmmOx7q2hlrgY+kA0zp8Er1VWitNxLnb2u4BEgRoRoElL07dksJLZ9oPYcd9UioJEEqSUpJTXynF
p3en6oFVhczWXD26AAGZRGyDu8Q7pdBsLxh5waXTs+xtgCeP5pLRWr1tQLsN7aMJvpOxxtxHH0yQ
fU/RlrmQJ41S0pWtvBUuxjlsYMfe42ACkux4cd30J9Pvwgl7/KZa7Htq+x15I9KsfZt4AdBd7Zc0
N0R0pGtvIYONPV7qB0puRZWHufiOsxw1gJHfaONw7oJe4rN++32M+mPzj+63+QnGkC3M6YK29QyT
RiZNVh3b7Mh1gqd7tfT3gt54jshorVsdQZddi5Ff2NmbL2/oC8CdGa/pGhunKRpQt5r6rUz1B5qw
RcaHBr7HPpHoE7vd+jYCfonhBL09+V1LHracTCGWXPs3BtzWbYcf9IAiaQHK6D1i/JDm9O6c51Lr
pusdlNfsL4kw7WABwEEupkl8YhgbvtZ0nTi7vCd1R0bPT/8Ak/G/4mv/AKkJqWwkpSSlJKUkpHaK
3bW2HQmIJgE+Hn8ERaCpwG9rRwQZASUkQSpJSklKSUpJTVzdsEu0iqw+oQ07Po+6HkDREbIO7zn2
pn/l9V/2zif3o34q+jrtFDsGx9gdcw4wLsmlrGucIfNjBWee4hK9N0ddnia/tXrt9S+z0t43bftO
/bOsS2JhD6pe3zm4oxbjdVdXX6Vc2UgeqBudq3aS6Ub03R12eVoON+0LvXyM77JB9L0/X9eZbG+W
7Y54QvxS9pWyvfb+rfnjsz91v8pEnxQPJodOeyzOyGfam5u3d+rNroaavd3LHbjHGqV+Kfov1VuG
3GsOSzIoZ6zffiwLJ2DT9HuMJEnugeTzvRNn7RAy7sp7DY30GV+t7ju0F3qNDY8UL8Uu51cYDaav
tQy8cepbtOHoT7vzvT3IknugeTidB9H12DOuy32m1npMp9b0najS31WjSefJC/FL1GSG7MQbNPtZ
9mn/AA3nCPVHRZvUBgdOwycfIyN9TBGPWbCIa36UcJq5h/zhZ/5X9R/9hnJKV/zhZ/5X9R/9hnJK
V/zhZ/5X9R/9hnJKdZJSzmtc0tcAQdCDqCkpZgAaIESBzz80ioMklKSUpJSklKSU4v1lzc3CZQ7C
BJfva/8ARi3T28hz2I2p579rdV/0Df8A2Er/APSyVqSN6/11n0A5ugbAxmAACY09fzStFOYyl1b2
2MxIc0hzT6HBGv8A3JStLu4HVOvZtzwcirFIaDvyKWsaYPAi12uqVopJT0/PozLOoVZ+A3JuBbZZ
tMkEg/vx+aErS2QeugkjqmD7jJ9nkB+/5JWimLGdYrcX19R6c1zuXNrAJ+J3JWlkD10EkdUwfcZP
s8gP3/JK0U1sPp+f099tmHn4FTryHWkNJ3ESRy8/vFK0tlp660QOqYPJP0PEz++laKa2D0/P6Yx1
eDn4FLXnc4BpMkafnPKVpdvJps24lW/9J6pdvjTf6dzpjw3JWinB+sVmzpfTP0Db5rGji8R7Gf6O
6n+KCXn/ALQP+4Nf+ff/AO9qSlfaB/3Br/z7/wD3tSUr7QP+4Nf+ff8A+9qSlfaB/wBwa/8APv8A
/e1JSvtA/wC4Nf8An3/+9qSlfaB/3Br/AM+//wB7UlK+0D/uDX/n3/8AvakpX2gf9wa/8+//AN7U
lOthfWTrwrbiYOHW9tTQGsZW95DRp/3JcUlNr9vfW7/yt/8AZez/ANLpKS4nVvrblZDaDhV0b5/S
XUWNYIBOpFx8ElK+uO/7NhevsNnu3+zc3dDZ27qbtElPLezwr/7aH/vEkpXs8K/+2h/7xJKV7PCv
/tof+8SSlezwr/7aH/vEkpXs8K/+2h/7xJKV7PCv/tof+8SSm/hdE6h1Cn7RiU0vr3FskVM1Hk/F
ae6Sk/8AzV61/wBx6Pvo/wDeZJSv+avWv+49H30f+8ySlf8ANXrX/cej76P/AHmSUr/mr1r/ALj0
ffR/7zJKeqya8n7NiU+oftGrfV0n1PQuG7iOfJJThfWSwV9K6XLA+axyxr49jP36bv4JKed+0j/Q
N/7Zq/8AeJJSvtI/0Df+2av/AHiSUr7SP9A3/tmr/wB4klK+0j/QN/7Zq/8AeJJSvtI/0Df+2av/
AHiSUr7SP9A3/tmr/wB4klK+0j/QN/7Zq/8AeJJSvtI/0Df+2av/AHiSUlx+p5GI82YrTQ8jaXVM
rYSOYluGPBJTY/5x9Y/7kX/9H/3kSU7fRPrVQMd1fVrLG2Nd7XuY+wuB/wCLoYBCSmH1xyaLMTBv
bDq7dz2E7myHBhGnq0nv3SU8t9oo8G/5zv8A3sSUr7RR4N/znf8AvYkpt9P63b0x77MM1tdYA127
36D+tlFJTd/56dU/fp/7bb/70pKV/wA9Oqfv0/8Abbf/AHpSUr/np1T9+n/ttv8A70pKV/z06p+/
T/223/3pSUr/AJ6dU/fp/wC22/8AvSkpX/PTqn79P/bbf/elJSv+enVP36f+22/+9KSm30/67WBz
m5zPXc4tFQoDGGdZmbnTOkJKd7JzH/Z8TN+z27vULvs8D1f5q72xPKSnI69i/ael9MEXnbWP5iv1
Dqxn0v01Mfikpwv2WfDO/wDYb/3+SUr9lnwzv/Yb/wB/klL/ALKPhnf+w3/v8kpPj9HNd7H5GN1G
6ppl9YxyzcPDcMwwkp0vsvRf/KPqf32f+9KSlfZei/8AlH1P77P/AHpSUyrwui2WNr/YvUmb3Bu5
5sDRJiSftPCSnU/5q9C/0D/+3rv/AEokpX/NXoX+gf8A9vXf+lElK/5q9C/0D/8At67/ANKJKV/z
V6F/oH/9vXf+lElOR9csVuPh4ONih7a6i8NDHPJAhvJ22H70lPK+jf8A8N99n/pFJSvRv/4b77P/
AEikpXo3/wDDffZ/6RSUr0b/APhvvs/9IpKV6N//AA332f8ApFJSvRv/AOG++z/0ikpXo3/8N99n
/pFJSvRv/wCG++z/ANIpKV6N/wDw332f+kUlK9G//hvvs/8ASKSnV6QelYrqsnObn2ZFb93ptbvq
PhIexpSU9hk57Ps+J1D0rdvqF/pbD6v81dps8UlOH9ZnUN6V0v1mtcPT03NDvzGeNtSSnnPVwf3K
v+22/wDvWkpXq4P7lX/bbf8A3rSUpt2E0hzWVggyD6be3/oWkp38H66vqe457jkNI9oY2quD/wBv
uSU3P+ffT/8AuPb/AJ1X/pRJSv8An30//uPb/nVf+lElK/599P8A+49v+dV/6USUr/n30/8A7j2/
51X/AKUSUr/n30//ALj2/wCdV/6USUr/AJ99P/7j2/51X/pRJSXF+unT8nIrx/SfX6rgze59e0SY
kxYkpD9dmtdVibo+k/lu7s3/AIK1JTynp1fyf8w/+8aSlenV/J/zD/7xpKV6dX8n/MP/ALxpKV6d
X8n/ADD/AO8aSlenV/J/zD/7xpKV6dX8n/MP/vGkpXp1fyf8w/8AvGkpXp1fyf8AMP8A7xpKV6dX
8n/MP/vGkpXp1fyf8w/+8aSk2Gxgy6S2uu472xW5pAcZ0BP2QQkp77Jfk+niWem37TuLvS3e31PQ
uO3fHE6TCSnB+sbHP6X0vbZ6cVjs8z7GfuVWpKee+z2/9yB/mXf+8aSlfZ7f+5A/zLv/AHjSUr7P
b/3IH+Zd/wC8aSlfZ7f+5A/zLv8A3jSUr7Pb/wByB/mXf+8aSnQxMbovoN+35WWL9dwoqJZE6Rvx
QeElJvs31Z/7l9Q/7a/99klK+zfVn/uX1D/tr/32SUr7N9Wf+5fUP+2v/fZJSvs31Z/7l9Q/7a/9
9klNjBxvq9XmUvruzbHB42stp9hJMDd+rt0+aSk/15ANOJIrPuf/ADm3wbxvexJTyWweGP8AfV/6
XSUrYPDH++r/ANLpKVsHhj/fV/6XSUrYPDH++r/0ukpWweGP99X/AKXSUrYPDH++r/0ukpWweGP9
9X/pdJStg8Mf76v/AEukpWweGP8AfV/6XSUrYPDH++r/ANLpKbXSjh1dQoszm0Ghr5fDq2x4Oltr
jodeElPeZOdieliZ/qt+zeoX+r+bt9K7VJTg/WSP2V0ufT/m/wDCis/mM49V7ElPOSPDG/zcf/0u
kpUjwxv83H/9LpKVI8Mb/Nx//S6SlSPDG/zcf/0ukpUjwxv83H/9LpKVI8Mb/Nx//S6SlSPDG/zc
f/0ukpUjwxv83H/9LpKVI8Mb/Nx//S6SkuNi5GZZ6WJVRdZG7bXXjuMDvAvSU9Fhv+uL8iqq4uqp
3APc6mmA0f1bCUlJProXCrF2gn3P4Fh7N/0Tm/ikp5dlt1b2vDXEtIIBbkEaeP6VJTrf86eqf9x8
f/2Gt/8ASiSnTo+tfTvRZ9pxLjdtHqenRDN3fbudMJKZ/wDOvo//AHEyf+2B/ekpX/Ovo/8A3Eyf
+2B/ekpX/Ovo/wD3Eyf+2B/ekpX/ADr6P/3Eyf8Atgf3pKV/zr6P/wBxMn/tgf3pKV/zr6P/ANxM
n/tgf3pKV/zr6P8A9xMn/tgf3pKb3S+p9P6sbBj0PrNW2RdWGTun6PM8JKbWS1vq4jYG31jpGn81
ckp536xGwdL6Z6d3ofoxJ9+vsZ/o6rUlPPb8j/ud+F3/ALyJKVvyP+534Xf+8iSlb8j/ALnfhd/7
yJKVvyP+534Xf+8iSnWxx0A0MOV1TMbdtHqBjHlod32zi8JKZ7fqz/5a5/8AmO/95UlK2/Vn/wAt
c/8AzHf+8qSlbfqz/wCWuf8A5jv/AHlSUrb9Wf8Ay1z/APMd/wC8qSmdbvq7U7dV1fqDHcS1rgfw
xUlJG5PRnENHW+pyTA+n/wC8ySkn12aPRww4boLxJG7s3/grUlPJ7Wfuj/M/99ElOtV9VerXVstZ
RUWvaHNJdUNCJGhx0lMv+aPWP+49X+fV/wCkElK/5o9Y/wC49X+fV/6QSUr/AJo9Y/7j1f59X/pB
JSv+aPWP+49X+fV/6QSUr/mj1j/uPV/n1f8ApBJSv+aPWP8AuPV/n1f+kElK/wCaPWP+49X+fV/6
QSUr/mj1j/uPV/n1f+kElJsb6vfWTCc52IBQXCHGu2tpI84oSU9Tkss24le4+pvLd3fd6N2qSnmv
rYxj+ldK3bdK/wA4gfmV+NjElPL+jV4V/wCc3/3oSUr0avCv/Ob/AO9CSlejV4V/5zf/AHoSUr0a
vCv/ADm/+9CSlejV4V/5zf8A3oSUr0avCv8Azm/+9CSlejV4V/5zf/ehJSvRq8K/85v/AL0JKV6N
XhX/AJzf/ehJSvRq8K/85v8A70JKbvS+pZPSLHPwn1sFhb6gms7g08S+50cpKel+uGRuxcG6t+1t
m5wIdtkEMI/wtSSnl/tL/wDTH/t3/wB+0lK+0v8A9Mf+3f8A37SUr7S//TH/ALd/9+0lK+0v/wBM
f+3f/ftJSvtL/wDTH/t3/wB+0lK+0v8A9Mf+3f8A37SUr7S//TH/ALd/9+0lK+0v/wBMf+3f/ftJ
SvtL/wDTH/t3/wB+0lK+0v8A9Mf+3f8A37SU9N9Uc9pDsauq2573A3Xh4exgh2yQbrCOCkp6LJ/n
sT/jj/56uSU819ZLvR6V0s+o6ua/zSRPsZ4XVJKec+2/92LP84/+9iSlfbf+7Fn+cf8A3sSUr7b/
AN2LP84/+9iSlfbf+7Fn+cf/AHsSUr7b/wB2LP8AOP8A72JKV9t/7sWf5x/97ElK+2/92LP84/8A
vYkpX23/ALsWf5x/97ElK+2/92LP84/+9iSlfbf+7Fn+cf8A3sSUzqy3OtY1t1ryXABrXEkmeAPt
iSnofrg6/KwsC2mmyvcXk1va8Pbo3RwqmElPLehnf6N3+bekpXoZ3+jd/m3pKV6Gd/o3f5t6Sleh
nf6N3+bekpXoZ3+jd/m3pKV6Gd/o3f5t6Skv7M60dRiX/wDbeT/5FJS/7M61/wBxL/8AtvJ/8ikp
X7M61/3Ev/7byf8AyKSlfszrX/cS/wD7byf/ACKSm/0XE+suPn1jFqfSXST9obkspO1rv5zQD4ea
Snrsn9pfZsT+Y+3bz+/6O/0rv7UJKcb6xGsdL6Z6m7+bEbSR+Yzwou/gkp57dj+Nv+ef/eFJTp0d
dxKKWUnp+NbsaG77GvL3R3cfsg1SUz/5xYn/AJV4f+ZZ/wC8qSlf84sT/wAq8P8AzLP/AHlSUr/n
Fif+VeH/AJln/vKkpX/OLE/8q8P/ADLP/eVJSv8AnFif+VeH/mWf+8qSlf8AOLE/8q8P/Ms/95Ul
NnB6iepWOqw+kYT3MbucDLNJjl+O1JTe+z9S/wDKTB/z2/8ApJJSm09TY4Ob0XBa5pkEWNBBH/Wk
lNT663214uC59de9xdva8VvAMMkA3Md+CSnk/ttn+jo/zMX/ANIpKV9ts/0dH+Zi/wDpFJSvttn+
jo/zMX/0ikpX22z/AEdH+Zi/+kUlK+22f6Oj/Mxf/SKSlfbbP9HR/mYv/pFJToD619fAAGTAGgE4
/wD6SSUr/nZ1/wD7lfjj/wDpJJSv+dnX/wDuV+OP/wCkklK/52df/wC5X44//pJJTt9Kz/rgQ3Lt
xTnY9tc1tNuPWNYIfLWA8JKejyf57E/44/8Anq5JTl5nSsnqnTcBuPY2s11NLt5sEyxv+iezw7pK
aH/NPqf/AHJq/wA7I/8AS6Slf80+p/8Acmr/ADsj/wBLpKV/zT6n/wByav8AOyP/AEukpX/NPqf/
AHJq/wA7I/8AS6Slf80+p/8Acmr/ADsj/wBLpKV/zT6n/wByav8AOyP/AEukpBnfV/PwMZ+Vbe17
WR7azkOeZIbo31/NJTlfpvC//tvJ/wDehJTd6e7p4Bb1GnOe9zgGGoXsAH8rdc5JT0n/ADZ6X43/
APb9v/k0lLs+rfTGPa9vry0gib7CJH9tJTn/AF0sDKsWbDXLn/RMTo3/AIan+KSnlvtA/wC5D/8A
P/8Af1JSvtA/7kP/AM//AN/UlK+0D/uQ/wDz/wD39SUr7QP+5D/8/wD9/UlK+0D/ALkP/wA//wB/
UlK+0D/uQ/8Az/8A39SUr7QP+5D/APP/APf1JSvtA/7kP/z/AP39SUr7QP8AuQ//AD//AH9SUzoz
nY9zL68h2+shzdzg4SPEOzSCkp6joHX3ZdhGfm0kvIrqpLWMe5xIgjZbZPMJKdvJ/nsT/jj/AOer
klOV1PKzMToGJbg2mmzbUC8NY4wWcRaWt/FJTj1Zv1vvYLKb8ixh4czGx3DTzD0dFO10vqXWNlOL
nYV9lpJD8qwMrbqSQS1hdEDRLRWrrzf+4z/OP/kEtEaqm/8AcZ/nH/yCWitVTf8AuM/zz/5BLRWq
pv8A3Gf5x/8AIJaK1Q5eIzPq9DMorurkO2ucYkd/oeaWitXjOpfVzLwLABN7XDduow6ntbJgNLnO
bqlorVvdF+q7rCMrOY19Xuaca/HZQ+ezpr3JaK1erHrNAAYwAaD3H/yCWitVTf8AuM/zj/5BLRWr
gfXBtj6cWLvQO58wLXTo3/Qj8qCXmPSu/wC5rv8AMy/7klK9G7/ua7/My/7klK9G7/ua7/My/wC5
JSvRu/7mu/zMv+5JSvRu/wC5rv8AMy/7klNzAq6cA/8AaeZlEyPT+zjIAjvu9RhSU2vT+rP/AHL6
l/4L/wCk0lK9P6s/9y+pf+C/+k0lK9P6s/8AcvqX/gv/AKTSUr0/qz/3L6l/4L/6TSU3Ol9N6Lm3
zh5WeX0xZFjnsGh/lMEpKegyf57E/wCOP/nq5JTjdagfVzF3BpEU/TNQH0P+7ALUlIfq5f1SgNrG
I+zEucNljX0CusS7c5ooaAZnVJT06SlJKUkpSSlJKUkpp9XLG4FhsIa3czVwaR9Nv77mj8UlNxJS
klKSU8v9eSBTiSax7n/zm3wbxvY9JTyW8eOP91X/AKQSUrePHH+6r/0gkpW8eOP91X/pBJSt48cf
7qv/AEgkpW8eOP8AdV/6QSUrePHH+6r/ANIJKVvHjj/dV/6QSUrePHH+6r/0gkpW8eOP91X/AKQS
UrePHH+6r/0gkp3/AKr9Q6P071cnOyaq73/o2tawaM0cTuqrbye3kkp6vJtrnEvn9H6hfu/k+jcZ
SU5XWC1v1dxS7iKfz6q/zP3rwWpKa/SvstrceuvrNldrojEbZS6DM7P0bIPySU9QkpSSlJKUkpSS
lJKc/rtH2jpllRc1suZq5rHj6be1vtSU6CSlJKUkp5v65tY6rF3l49z42Dd2bz+mp/ikp5b06I+l
d/mf+/qSlenR+9d/mf8Av6kpXp0fvXf5n/v6kpQrx5G43ETqNn/v6kp1PV+qv/cLO/7cH/vQkpXq
/VX/ALhZ3/bg/wDehJSvV+qv/cLO/wC3B/70JKV6v1V/7hZ3/bg/96ElNr7D0j/yn6r/ANL/ANLp
KV9h6R/5T9V/6X/pdJSvsPSP/Kfqv/S/9LpKd/JzD6GJmehdPqF3obR6v81d7du6J+aSml1OnKv6
BiV4lVt1m2o7aXtrdAZqdz2vCVKcBuD1ml7H24+Zjt3AG05VI2z3/mQjSLewq6hg11MrOQHljQ0v
dMugRJ05SpVsv2ngf6Zv4pUq1ftPA/0zfxSpVq/aeB/pm/j/AHJUq1ftPA/0zfxSpVq/aeB/pm/i
lSrc3rHVyWfZsSgZTHhrnWCytoaWu3bdtvPCVKtt4fWab6BZltGLZJBqLxZp47maJUq046lgkwLm
knga/wByVKtN6zPB/wDmO/8AIpUq3nfrnaG04jvTD5c/6TGujRvaym2PwQS8t9pH+gb/ANs1f+8S
SlfaR/oG/wDbNX/vEkpX2kf6Bv8A2zV/7xJKV9pH+gb/ANs1f+8SSlfaR/oG/wDbNX/vEkpX2kf6
Bv8A2zV/7xJKV9pH+gb/ANs1f+8SSlfaR/oG/wDbNX/vEkpu/wDOPrH/AHIv/wCj/wC8iSlf84+s
f9yL/wDo/wDvIkpJj/WDqVl7GZGZkU1OMPsDQ/aPHaMUSkp6/Jou9LEx/Xd6u8t+0QN270bvfERK
SmrkdZZ0fpuC59fqerU0D9IyuNrW/wCkc2eUlOP1b6yYvVcM4j6fTBcHbhdju48nPISU4np9P8T/
AJ2H/ekpXp9P8T/nYf8AekpXp9P8T/nYf96Slen0/wAT/nYf96Slen0/xP8AnYf96SnRqzvq7XUx
lnTKrHNaA55uoBcQNXECyNUlM/2h9Wv/ACpp/wC36f8A0okpX7Q+rX/lTT/2/T/6USUuzqf1cY4P
Z0qoOaQQRfToR/1xJT0GH9Z+lZFIsvvqxnyR6b7WOMDvLHEJKc365WY1uNhWm0iuwucx1cODgQ0g
63U/xSU8tOH/ANyLf81v/vakpU4f/ci3/Nb/AO9qSlTh/wDci3/Nb/72pKVOH/3It/zW/wDvakpU
4f8A3It/zW/+9qSlTh/9yLf81v8A72pKdLDzPqtVjMZmY+RfcJ32Ns2AyTHtGZ4JKT/tD6mf9wsr
/t//AN+0lK/aH1M/7hZX/b//AL9pKV+0PqZ/3Cyv+3//AH7SU2+ku+qvUc5mPiYmQ23V7XPuJaNn
u125L/yJKemyf57E/wCOP/nq5JTzn1ha53S+mbWWP/Rj+bc9sexnPpsekpwqTbTcy4UXPNbg8Ne6
9zTtMw4ehqElOr/zhyv/ACro/wC2rf8A0ikpX/OHK/8AKuj/ALat/wDSKSlf84cr/wAq6P8Atq3/
ANIpKV/zhyv/ACro/wC2rf8A0ikpX/OHK/8AKuj/ALat/wDSKSlf84cr/wAq6P8Atq3/ANIpKV/z
hyv/ACro/wC2rf8A0ikpX/OHK/8AKuj/ALat/wDSKSlf84cr/wAq6P8Atq3/ANIpKTYfW78jKqpt
6ZS1j3ta9zarZAJidaQElNj65UXvpxGYrHENLxFbS6BDY+hXYkp5f7H1L/R3f9t2f+8ySlfY+pf6
O7/tuz/3mSUr7H1L/R3f9t2f+8ySlfY+pf6O7/tuz/3mSUr7H1L/AEd3/bdn/vMkpX2PqX+ju/7b
s/8AeZJSvsfUv9Hd/wBt2f8AvMkpX2PqX+ju/wC27P8A3mSUr7J1L/R3f9t2f+8ySlfY+pf6O7/t
uz/3mSU3uk9L67bebcMupfVBJsLqpBPGtDZ41SU9bku6j9nxHbKvtvqH2yfS3+ld35hJTh/WYVHp
XS/VMfo9NKz+ZX/piPwSU83GH+//ANHG/wDJpKVGH+//ANHG/wDJpKVGH+//ANHG/wDJpKVGH+//
ANHG/wDJpKVGH+//ANHG/wDJpKVGH+//ANHG/wDJpKVGJ+//ANHG/wDJpKVGH+//ANHG/wDJpKbn
T8no2L6n2zFbm79uzcaK9kTP0H6zKSm5+1Pqx/5UV/8AbtX/AJNJTp/V7qHQrs/08PDZiXuYQxwe
x5cBqWjY49hKSmP16j0cOQw+6z6e3wbxvexJTyPtiIp/8D/9LJKV7P3af/A//SySlez92n/wP/0s
kpXs/dp/8D/9LJKV7P3af/A//SySlez92n/wP/0skpXs/dp/8D/9LJKV7P3af/A//SySlez92n/w
P/0skpXs/dp/8D/9LJKdj6qDK/a7Dh+m1sRe5jaz+jkEgxa4iSAkp7fJ/nsT/jj/AOerklNP9mUd
S6dhNvfaz06mEek8s5a3nb8ElI/+a3T/APTZX/b7/wC9JSv+a3T/APTZX/b7/wC9JSv+a3T/APTZ
X/b7/wC9JSv+a3T/APTZX/b7/wC9JSv+a3T/APTZX/b7/wC9JSv+a3T/APTZX/b7/wC9JSv+a3T/
APTZX/b7/wC9JTfxOn42HQ2hgL2tk7rTvdqZ1c7VJSb0af8ARt+4JKV6NP8Ao2/cElKFVbTLWNBH
cABJTz31z/msXV49z/oNe7s3/RvYkp5aP5d3/bd3/pdJSo/l3f8Abd3/AKXSUqP5d3/bd3/pdJSo
/l3f9t3f+l0lKj+Xd/21d/6XSUqP5d3/AG1d/wClklKj+Xd/23d/6XSU2sF3TG7/ANojNsmPT9Bt
jY53bt1rvJJTa9T6s/6Lqf3u/wDJJKV6n1Z/0XU/vd/5JJTa6fidCz8hlGPX1JhfI9R5e1g2gu1d
u8klO/k4VXoYmBL/AEtxq3bjvj0bh9LmUlNjp/8Ayfjf8TX/ANSElNhJSklKSUpJSklKSUpJSklK
SUpJSklPMfXgA1YkgH3P5G7s3/grUlPJbWfuj/M/99ElK2s/dH+Z/wC+iSlbWfuj/M/99ElK2s/d
H+Z/76JKVtZ+6P8AM/8AfRJStrP3R/mf++iSlbWfuj/M/wDfRJStrP3R/mf++iSlbWfuj/M/99El
K2s/dH+Z/wC+iSnR6Rn9Qx8mnHwnu2usBFEmtj3Hs6MZvKSnuMk2TiO2j1PUJ2zpu9G7SfikpF0/
qGAMDGByaQRTXI9Rv7o80lNj9odP/wC5NP8A243+9JSv2h0//uTT/wBuN/vSUr9odP8A+5NP/bjf
70lK/aHT/wDuTT/243+9JSv2h0//ALk0/wDbjf70lK/aHT/+5NP/AG43+9JSv2h0/wD7k0/9uN/v
SUr9odP/AO5NP/bjf70lK/aHT/8AuTT/ANuN/vSUr9odP/7k0/8Abjf70lK/aHT/APuTT/243+9J
TUz6+gdTDG51lFwrJLAbQInn6Lh4JKan7E+p/wC5jf8Abp/9KJKb2E7onTqfs+FbRVXJdtFgOp76
uPgkpsftDp//AHJp/wC3G/3pKV+0On/9yaf+3G/3pKV+0On/APcmn/txv96SlftDp/8A3Jp/7cb/
AHpKV+0On/8Acmn/ALcb/ekpX7Q6f/3Jp/7cb/ekpX7Q6f8A9yaf+3G/3pKV+0On/wDcmn/txv8A
ekpX7Q6f/wByaf8Atxv96Smvk9QwDdixk06XGf0jf9Fb5pKf/9k=
2
JPEG
256
256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611
application/pdf
071966173.indd
Adobe PDF Library 9.9
False
PDF/X-1:2001
PDF/X-1:2001
PDF/X-1a:2001
endstream
endobj
3 0 obj
<>
endobj
6 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/Properties<>>>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page>>
endobj
7 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page>>
endobj
8 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page>>
endobj
9 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/Properties<>>>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page>>
endobj
23 0 obj
<>stream
BT
/CS0 cs 1 scn
/GS0 gs
/T1_0 1 Tf
6.5 0 0 6.5 13.5 773.8331 Tm
(The following treatment-related clinical adverse events occurred at an i\
ncidence of 1% or greater in 4048 )Tj
0 -1.015 TD
(patients receiving fluconazole for 7 or more days in clinical trials: na\
usea\0373.7%, headache 1.9%, skin rash 1.8%, )Tj
0 -1.015 TD
(vomiting 1.7%, abdominal pain 1.7%, and diarrhea 1.5%. )Tj
/T1_1 1 Tf
0 -1.237 TD
[(Hepatobiliar)-18(y: )]TJ
/T1_0 1 Tf
(In combined clinical trials and marketing experience, there have been ra\
re cases of serious )Tj
0 -1.015 TD
(hepatic reactions during treatment with fluconazole. \(See )Tj
/T1_2 1 Tf
(W)Tj
/Span<>> BDC
23.475 0 Td
(A)Tj
EMC
(RNIN)Tj
/Span<>> BDC
(G)Tj
EMC
(S)Tj
/T1_0 1 Tf
(.\) The spectrum of these hepatic reactions )Tj
-23.475 -1.015 Td
(has ranged from mild transient elevations in transaminases to clinical h\
epatitis, cholestasis and fulminant )Tj
T*
(hepatic failure, including fatalities. Instances of fatal hepatic reacti\
ons were noted to occur primarily in patients )Tj
T*
(with serious underlying medical conditions \(predominantly AIDS or malig\
nancy\) and often while taking multiple )Tj
T*
[(concomitant medications. T)74(ransient hepatic reactions, including hepatitis and jaundice, have occur\
red among )]TJ
0 -1.015 TD
(patients with no other identifiable risk factors. In each of these cases\
, liver function returned to baseline on )Tj
0 -1.015 TD
(discontinuation of fluconazole. )Tj
0 -1.237 TD
[(In two comparative trials evaluating the efficacy of fluconazole for the\
suppression of relapse of cr)-18(yptococcal )]TJ
0 -1.015 TD
[(meningitis, a statistically significant increase was obser)-18(ved in median AST \(SGOT\) levels from a baseline value )]TJ
T*
[(of 30 IU/L to 41 IU/L in one trial and 34 IU/L to 66 IU/L in the other)74(. The overall rate of serum transaminase )]TJ
T*
(elevations of more than 8 times the upper limit of normal was approximat\
ely 1% in fluconazole-treated patients )Tj
T*
(in clinical trials. These elevations occurred in patients with severe un\
derlying disease, predominantly AIDS )Tj
T*
(or malignancies, most of whom were receiving multiple concomitant medica\
tions, including many known )Tj
T*
(to be hepatotoxic. The incidence of abnormally elevated serum transamina\
ses was greater in patients taking )Tj
T*
(fluconazole concomitantly with one or more of the following medications:\
rifampin, phenytoin, isoniazid, )Tj
T*
(valproic acid, or oral sulfonylurea hypoglycemic agents. )Tj
0 -1.237 TD
(Post-Marketing Experience)Tj
0 -1.237 TD
(In addition, the following adverse events have occurred during postmarke\
ting experience.)Tj
/T1_1 1 Tf
T*
(Immunologic: )Tj
/T1_0 1 Tf
(In rare cases, anaphylaxis \(including angioedema, face edema and prurit\
us\) has been reported.)Tj
/T1_1 1 Tf
0 -1.237 TD
(Cardiovascular:)Tj
/T1_0 1 Tf
( QT prolongation, torsade de pointes. \(See )Tj
/T1_2 1 Tf
(PREC)Tj
/Span<>> BDC
(A)Tj
EMC
(UTIONS)Tj
/T1_0 1 Tf
(.\) )Tj
/T1_1 1 Tf
0 -1.237 TD
[(Central Ner)-18(vous System: )]TJ
/T1_0 1 Tf
(Seizures, dizziness. )Tj
/T1_1 1 Tf
T*
(Dermatologic: )Tj
/T1_0 1 Tf
(Exfoliative skin disorders including Stevens-Johnson syndrome and toxic \
epidermal necrolysis )Tj
0 -1.015 TD
(\(see )Tj
/T1_2 1 Tf
(W)Tj
/Span<>> BDC
2.73 0 Td
(A)Tj
EMC
(RNIN)Tj
/Span<>> BDC
(G)Tj
EMC
(S)Tj
/T1_0 1 Tf
(\), alopecia. )Tj
/T1_1 1 Tf
-2.73 -1.237 Td
(Hematopoietic)Tj
/T1_0 1 Tf
( and )Tj
/T1_1 1 Tf
[(L)37(ymphatic:)]TJ
/T1_0 1 Tf
( Leukopenia, including neutropenia and agranulocytosis, thrombocytopenia\
. )Tj
/T1_1 1 Tf
0 -1.237 TD
(Metabolic: )Tj
/T1_0 1 Tf
[(Hyper)20(cholesterolemia, hypertriglyceridemia, hypokalemia.)]TJ
/T1_1 1 Tf
0 -1.237 TD
(Gastrointestinal)Tj
/T1_0 1 Tf
(: Dyspepsia, vomiting.)Tj
/T1_1 1 Tf
0 -1.237 TD
(Other senses)Tj
/T1_0 1 Tf
[(: T)74(aste per)-18(version.)]TJ
/T1_2 1 Tf
/Span<>> BDC
7 0 0 7 13.5 549.6934 Tm
(A)Tj
EMC
(dverse Reactions in Children:)Tj
/T1_0 1 Tf
6.5 0 0 6.5 13.5 542.3734 Tm
(In Phase II/III clinical trials conducted in the United States and in Eu\
rope, 577 pediatric patients, ages 1 day )Tj
0 -1.015 TD
[(to 17 years were treated with fluconazole at doses up to 15 mg/kg/day fo\
r up to 1,616 days. Thirteen per)20(cent )]TJ
T*
(of children experienced treatment related adverse events. The most commo\
nly reported events were vomiting )Tj
0 -1.015 TD
[(\(5%\), abdominal pain \(3%\), nausea \(2%\), and diarrhea \(2%\). T)74(reatment was discontinued in 2.3% of patients )]TJ
0 -1.015 TD
[(due to adverse clinical events and in 1.4% of patients due to laborator)-18(y test abnormalities. The majority of )]TJ
0 -1.015 TD
[(treatment-related laborator)-18(y abnormalities were elevations of transaminases or alkaline phosphatase\
.)]TJ
/T1_2 1 Tf
10.023 -1.154 Td
[(Percentage of Patients With T)74(reatment-Related Side Effects)]TJ
5.999 -1.134 Td
(Fluconazole)Tj
( )Tj
0.806 -1.031 Td
(\(N=577\))Tj
14.2 1.031 Td
(Comparative )Tj
/Span<>> BDC
(A)Tj
EMC
(gents)Tj
( )Tj
2.459 -1.031 Td
(\(N=451\))Tj
/T1_0 1 Tf
-33.044 -1.126 Td
(With any side effect)Tj
17.149 0 Td
(13.0)Tj
16.909 0 Td
(9.3)Tj
-34.058 -1.13 Td
[(V)18(omiting)]TJ
17.399 0 Td
(5.4)Tj
16.659 0 Td
(5.1)Tj
-34.058 -1.13 Td
(Abdominal pain)Tj
17.399 0 Td
(2.8)Tj
16.659 0 Td
(1.6)Tj
-34.058 -1.13 Td
(Nausea)Tj
17.399 0 Td
(2.3)Tj
16.659 0 Td
(1.6)Tj
-34.058 -1.13 Td
(Diarrhea)Tj
17.399 0 Td
(2.1)Tj
16.659 0 Td
(2.2)Tj
/T1_2 1 Tf
7.5 0 0 7.5 13.5 440.5308 Tm
(OVERDOS)Tj
/Span<>> BDC
(AG)Tj
EMC
(E)Tj
/T1_0 1 Tf
6.5 0 0 6.5 13.5 433.2108 Tm
[(There have been reports of overdosage with fluconazole. A 42-year)37(-old patient infected with human )]TJ
T*
(immunodeficiency virus developed hallucinations and exhibited paranoid b\
ehavior after reportedly ingesting )Tj
0 -1.015 TD
(8200 mg of fluconazole. The patient was admitted to the hospital, and hi\
s condition resolved within 48 hours. )Tj
0 -1.237 TD
(In the event of overdose, symptomatic treatment \(with supportive measur\
es and gastric lavage if clinically )Tj
0 -1.015 TD
(indicated\) should be instituted. )Tj
0 -1.237 TD
(Fluconazole is largely excreted in urine. A three-hour hemodialysis sess\
ion decreases plasma levels by )Tj
0 -1.015 TD
(approximately 50%. )Tj
0 -1.237 TD
[(In mice and rats receiving ver)-18(y high doses of fluconazole, clinical effects in both species included d\
ecreased )]TJ
0 -1.015 TD
[(motility and respiration, ptosis, lacrimation, salivation, urinar)-18(y incontinence, loss of righting reflex and cyanosis; )]TJ
0 -1.015 TD
(death was sometimes preceded by clonic convulsions.)Tj
/T1_2 1 Tf
7.5 0 0 7.5 13.5 358.8108 Tm
(DOS)Tj
/Span<>> BDC
(AG)Tj
EMC
(E )Tj
/Span<>> BDC
(A)Tj
EMC
(ND )Tj
/Span<>> BDC
(A)Tj
EMC
(D)Tj
/Span<>> BDC
(M)Tj
EMC
(INISTR)Tj
/Span<>> BDC
(A)Tj
EMC
11.003 0 Td
(TION)Tj
6.5 0 0 6.5 13.5 351.4908 Tm
(Dosage and )Tj
/Span<>> BDC
(A)Tj
EMC
(dministration in )Tj
/Span<>> BDC
(A)Tj
EMC
(dults:)Tj
/T1_0 1 Tf
0 -1.237 TD
[(SINCE ORAL ABSORPTION IS RAPID AND ALMOST COMPLETE, THE DAIL)92(Y DOSE OF FLUCONAZOLE IS THE )]TJ
0 -1.015 TD
[(SAME FOR ORAL AND INTRA)37(VENOUS ADMINISTRA)55(TION. In general, a loading dose of twice the daily dose is )]TJ
0 -1.015 TD
(recommended on the first day of therapy to result in plasma concentratio\
ns close to steady-state by the second )Tj
0 -1.015 TD
[(day of therapy)55(. )]TJ
0 -1.237 TD
(The daily dose of Fluconazole Injection, USP for the treatment of infect\
ions should be based on the infecting )Tj
0 -1.015 TD
[(organism and the patient\222)55(s response to therapy)55(. T)74(reatment should be continued until clinical parameters or )]TJ
0 -1.015 TD
[(laborator)-18(y tests indicate that active fungal infection has subsided. An inadequat\
e period of treatment may lead )]TJ
T*
[(to recurrence of active infection. Patients with AIDS and cr)-18(yptococcal meningitis or recurrent orophar)-18(yngeal )]TJ
0 -1.015 TD
(candidiasis usually require maintenance therapy to prevent relapse. )Tj
/T1_1 1 Tf
0 -1.237 TD
[(Orophar)-18(yngeal candidiasis: )]TJ
/T1_0 1 Tf
[(The recommended dosage of Fluconazole Injection, USP for orophar)-18(yngeal )]TJ
0 -1.015 TD
[(candidiasis is 200 mg on the first day)55(, followed by 100 mg once daily)55(. Clinical evidence of orophar)-18(yngeal )]TJ
0 -1.015 TD
(candidiasis generally resolves within several days, but treatment should\
be continued for at least 2 weeks to )Tj
T*
(decrease the likelihood of relapse. )Tj
/T1_1 1 Tf
0 -1.237 TD
(Esophageal candidiasis: )Tj
/T1_0 1 Tf
(The recommended dosage of Fluconazole Injection, USP for esophageal cand\
idiasis )Tj
0 -1.015 TD
[(is 200\037mg on the first day)55(, followed by 100 mg once daily)55(. Doses up to 400 mg/day may be used, based on )]TJ
0 -1.015 TD
[(medical judgment of the patient\222)55(s response to therapy)55(. Patients with esophageal candidiasis should be treated )]TJ
0 -1.015 TD
(for a minimum of three weeks and for at least two weeks following resolu\
tion of symptoms. )Tj
/T1_1 1 Tf
0 -1.237 TD
(Systemic Candida infections: )Tj
/T1_0 1 Tf
(For systemic)Tj
/T1_1 1 Tf
( Candida)Tj
/T1_0 1 Tf
( infections including candidemia, disseminated candidiasis, )Tj
0 -1.015 TD
(and pneumonia, optimal therapeutic dosage and duration of therapy have n\
ot been established. In open, )Tj
T*
(noncomparative studies of small numbers of patients, doses of up to 400 \
mg daily have been used. )Tj
/T1_1 1 Tf
0 -1.237 TD
[(Urinar)-18(y tract infections and peritonitis: )]TJ
/T1_0 1 Tf
(For the treatment of )Tj
/T1_1 1 Tf
(Candida)Tj
/T1_0 1 Tf
[( urinar)-18(y tract infections and peritonitis, daily )]TJ
0 -1.015 TD
(doses of 50-200 mg have been used in open, noncomparative studies of sma\
ll numbers of patients. )Tj
/T1_1 1 Tf
0 -1.237 TD
[(Cr)-18(yptococcal meningitis: )]TJ
/T1_0 1 Tf
[(The recommended dosage for treatment of acute cr)-18(yptococcal meningitis is 400\037mg )]TJ
0 -1.015 TD
[(on the first day)55(, followed by 200 mg once daily)55(. A dosage of 400 mg once daily may be used, based on )]TJ
0 -1.015 TD
[(medical judgment of the patient\222)55(s response to therapy)55(. The recommended duration of treatment for initial )]TJ
0 -1.015 TD
[(therapy of cr)-18(yptococcal meningitis is 10-12 weeks after the cerebrospinal fluid becom\
es culture negative. The )]TJ
0 -1.015 TD
[(recommended dosage of Fluconazole Injection, USP for suppression of rela\
pse of cr)-18(yptococcal meningitis in )]TJ
0 -1.015 TD
[(patients with AIDS is 200 mg once daily)55(. )]TJ
/T1_1 1 Tf
0 -1.237 TD
(Prophylaxis in patients undergoing bone marrow transplantation: )Tj
/T1_0 1 Tf
(The recommended Fluconazole Injection, USP )Tj
0 -1.015 TD
(daily dosage for the prevention of candidiasis in patients undergoing bo\
ne marrow transplantation is 400 mg, )Tj
0 -1.015 TD
[(once daily)55(. Patients who are anticipated to have severe granulocytopenia \(less th\
an 500 neutrophils per cu mm\) )]TJ
T*
(should start Fluconazole Injection, USP prophylaxis several days before \
the anticipated onset of neutropenia, )Tj
0 -1.015 TD
(and continue for 7 days after the neutrophil count rises above 1000 cell\
s per cu mm.)Tj
/T1_2 1 Tf
0 -1.363 TD
(Dosage and )Tj
/Span<>> BDC
(A)Tj
EMC
(dministration in Children:)Tj
/T1_0 1 Tf
0 -1.126 TD
(The following dose equivalency scheme should generally provide equivalen\
t exposure in pediatric and adult )Tj
0 -1.015 TD
(patients:)Tj
ET
/CS0 CS 1 SCN
0.325 w
q 1 0 0 1 61.9344 91.935 cm
0 0 m
47.131 0 l
S
Q
BT
/T1_2 1 Tf
6.5 0 0 6.5 61.9344 92.5849 Tm
(Pediatric Patients)Tj
ET
q 1 0 0 1 221.1931 91.935 cm
0 0 m
16.614 0 l
S
Q
BT
/T1_2 1 Tf
/Span<>> BDC
6.5 0 0 6.5 221.1931 92.5849 Tm
(A)Tj
EMC
(dults)Tj
/T1_0 1 Tf
-22.501 -1.061 Td
(3 mg/kg)Tj
22.265 0 Td
(100 mg)Tj
-22.265 -1.189 Td
(6 mg/kg)Tj
22.265 0 Td
(200 mg)Tj
-22.765 -1.189 Td
(12* mg/kg)Tj
22.765 0 Td
(400 mg)Tj
-30.64 -1.251 Td
(* Some older children may have clearances similar to that of adults. Abs\
olute doses exceeding 600 mg/day )Tj
0.769 -1.015 Td
(are not recommended.)Tj
43.846 110.513 Td
(Experience with fluconazole in neonates is limited to pharmacokinetic st\
udies in premature newborns. \(See )Tj
/T1_2 1 Tf
0 -1.015 TD
(C)Tj
/Span<>> BDC
(L)Tj
EMC
(INIC)Tj
/Span<>> BDC
(AL)Tj
EMC
( P)Tj
/Span<>> BDC
(HA)Tj
EMC
(R)Tj
/Span<>> BDC
(MA)Tj
EMC
(CO)Tj
/Span<>> BDC
(L)Tj
EMC
(O)Tj
/Span<>> BDC
(GY)Tj
EMC
/T1_0 1 Tf
(.\) Based on the prolonged half-life seen in premature newborns \(gestat\
ional age )Tj
0 -1.015 TD
(26\037to 29 weeks\), these children, in the first two weeks of life, sho\
uld receive the same dosage \(mg/kg\) as in )Tj
0 -1.015 TD
[(older children, but administered ever)-18(y 72 hours. After the first two weeks, these children should be dosed on\
ce )]TJ
T*
[(daily)55(. No information regarding fluconazole pharmacokinetics in full-term new\
borns is available. )]TJ
/T1_1 1 Tf
0 -1.237 TD
[(Orophar)-18(yngeal candidiasis: )]TJ
/T1_0 1 Tf
[(The recommended dosage of Fluconazole Injection, USP for orophar)-18(yngeal )]TJ
0 -1.015 TD
[(candidiasis in children is 6 mg/kg on the first day)55(, followed by 3 mg/kg once daily)55(. T)74(reatment should be )]TJ
0 -1.015 TD
(administered for at least 2 weeks to decrease the likelihood of relapse.\
)Tj
/T1_1 1 Tf
0 -1.237 TD
(Esophageal candidiasis: )Tj
/T1_0 1 Tf
(For the treatment of esophageal candidiasis, the recommended dosage of F\
luconazole )Tj
0 -1.015 TD
[(Injection, USP in children is 6 mg/kg on the first day)55(, followed by 3 mg/kg once daily)55(. Doses up to 12 mg/kg/)]TJ
0 -1.015 TD
[(day may be used based on medical judgment of the patient\222)55(s response to therapy)55(. Patients with esophageal )]TJ
0 -1.015 TD
(candidiasis should be treated for a minimum of 3 weeks and for at least \
2 weeks following the resolution of )Tj
T*
(symptoms. )Tj
/T1_1 1 Tf
0 -1.237 TD
(Systemic Candida infections: )Tj
/T1_0 1 Tf
(For the treatment of candidemia and disseminated )Tj
/T1_1 1 Tf
(Candida)Tj
/T1_0 1 Tf
( infections, daily doses )Tj
0 -1.015 TD
(of 6-12 mg/kg/day have been used in an open, noncomparative study of a s\
mall number of children. )Tj
/T1_1 1 Tf
0 -1.237 TD
[(Cr)-18(yptococcal meningitis: )]TJ
/T1_0 1 Tf
[(For the treatment of acute cr)-18(yptococcal meningitis, the recommended dosage is )]TJ
0 -1.015 TD
[(12\037mg/kg on the first day)55(, followed by 6 mg/kg once daily)55(. A dosage of 12 mg/kg once daily may be used, based )]TJ
T*
[(on medical judgment of the patient\222)55(s response to therapy)55(. The recommended duration of treatment for initial )]TJ
T*
[(therapy of cr)-18(yptococcal meningitis is 10-12 weeks after the cerebrospinal fluid becom\
es culture negative. For )]TJ
T*
[(suppression of relapse of cr)-18(yptococcal meningitis in children with AIDS, the recommended dose of Flu\
conazole )]TJ
T*
[(Injection, USP is 6 mg/kg once daily)55(. )]TJ
/T1_2 1 Tf
0 -1.363 TD
(Dosage In Patients With Impaired Renal Function:)Tj
/T1_0 1 Tf
0 -1.126 TD
(Fluconazole is cleared primarily by renal excretion as unchanged drug. I\
n patients with impaired renal function )Tj
0 -1.015 TD
[(who will receive multiple doses of Fluconazole Injection, USP)129(, an initial loading dose of 50 to 400 mg should be )]TJ
0 -1.015 TD
(given. After the loading dose, the daily dose \(according to indication\)\
should be based on the following table:)Tj
ET
q 1 0 0 1 342.9489 598.4963 cm
0 0 m
81.978 0 l
S
Q
BT
/T1_2 1 Tf
6.5 0 0 6.5 342.9489 599.1463 Tm
(Creatinine Clearance \(m)Tj
/Span<>> BDC
(L)Tj
EMC
(/min\))Tj
ET
q 1 0 0 1 486.3217 598.4963 cm
0 0 m
83.232 0 l
S
Q
BT
/T1_2 1 Tf
6.5 0 0 6.5 486.3217 599.1463 Tm
(Percent of Recommended Dose)Tj
/T1_0 1 Tf
-16.501 -1.174 Td
(>50)Tj
21.737 0 Td
(100%)Tj
-24.301 -1.071 Td
(\03450 \(no dialysis\))Tj
24.551 0 Td
(50%)Tj
-24.36 -1.071 Td
(Regular dialysis)Tj
20.46 0 Td
(100% after each dialysis)Tj
-28.635 -1.479 Td
(These are suggested dose adjustments based on pharmacokinetics following\
administration of multiple doses. )Tj
0 -1.015 TD
(Further adjustment may be needed depending upon clinical condition. )Tj
0 -1.237 TD
(When serum creatinine is the only measure of renal function available, t\
he following formula \(based on sex, )Tj
0 -1.015 TD
(weight, and age of the patient\) should be used to estimate the creatini\
ne clearance in adults:)Tj
ET
0.5 w
/GS1 gs
q 1 0 0 1 419.454 536.6036 cm
0 0 m
111.048 0 l
S
Q
BT
/GS0 gs
/T1_0 1 Tf
6.5 0 0 6.5 387.5 539.1888 Tm
(Males:)Tj
8.483 0 Td
[(W)18(eight \(kg\) x \(140 - age\))]TJ
-2.037 -1.337 Td
(72 x serum creatinine \(mg/100 mL\))Tj
-6.446 -1.125 Td
(Females:)Tj
9.793 0 Td
(0.85 x above value)Tj
-21.639 -1.438 Td
[(Although the pharmacokinetics of fluconazole has not been studied in chi\
ldren with renal insufficiency)55(, dosage )]TJ
T*
(reduction in children with renal insufficiency should parallel that reco\
mmended for adults. The following formula )Tj
T*
(may be used to estimate creatinine clearance in children:)Tj
ET
/GS1 gs
q 1 0 0 1 419.0545 490.212 cm
0 0 m
90.953 0 l
S
Q
BT
/GS0 gs
/T1_0 1 Tf
6.5 0 0 6.5 405.5296 487.9494 Tm
(K x)Tj
3.551 0.791 Td
(Linear length or height \(cm\))Tj
-0.57 -1.382 Td
(Serum creatinine \(mg/100 mL\))Tj
-17.601 -1.215 Td
(\(Where K=0.55 for children older than 1 year and 0.45 for infants.\))Tj
/T1_2 1 Tf
/Span<>> BDC
0 -1.363 TD
(A)Tj
EMC
(dministration)Tj
/T1_0 1 Tf
0 -1.126 TD
(Fluconazole Injection, USP is administered by intravenous infusion. Fluc\
onazole has been used safely for up )Tj
0 -1.015 TD
[(to fourteen days of intravenous therapy)55(. The intravenous infusion of Fluconazole Injection, USP should be )]TJ
0 -1.015 TD
[(administered at a maximum rate of approximately 200 mg/hour)74(, given as a continuous infusion. )]TJ
0 -1.237 TD
[(Fluconazole Injection, USP in INTRA)37(VIA plastic containers is intended only for intravenous administration u\
sing )]TJ
0 -1.015 TD
(sterile equipment. )Tj
0 -1.237 TD
(Parenteral drug products should be inspected visually for particulate ma\
tter and discoloration prior to )Tj
0 -1.015 TD
(administration whenever solution and container permit. )Tj
0 -1.237 TD
(Do not use if the solution is cloudy or precipitated or if the seal is n\
ot intact. )Tj
/T1_2 1 Tf
0 -1.363 TD
(Directions for IV Use of Fluconazole Injection, USP in INTR)Tj
/Span<>> BDC
(A)Tj
EMC
24.492 0 Td
(VI)Tj
/Span<>> BDC
(A)Tj
EMC
( Plastic Containers)Tj
/T1_0 1 Tf
-24.492 -1.126 Td
[(Do not remove unit from over)-18(wrap until ready for use. The over)-18(wrap is a moisture barrier)74(. The inner bag )]TJ
0 -1.015 TD
(maintains the sterility of the product. )Tj
/T1_2 1 Tf
0 -1.237 TD
(C)Tj
/Span<>> BDC
(A)Tj
EMC
(UTION:)Tj
/T1_0 1 Tf
( Do not use plastic containers in series connections. Such use could res\
ult in air embolism due to )Tj
0 -1.015 TD
[(residual air being drawn from the primar)-18(y container before administration of the fluid from the secondar)-18(y )]TJ
0 -1.015 TD
(container is completed. )Tj
/T1_2 1 Tf
0 -1.474 TD
[(T)74(o Open)]TJ
/T1_0 1 Tf
0 -1.126 TD
[(T)74(ear over)-18(wrap down side at slit and remove solution container)74(. Some opacity of the plastic due to moisture )]TJ
0 -1.015 TD
[(absorption during the sterilization process may be obser)-18(ved. This is normal and does not affect the solution )]TJ
0 -1.015 TD
[(quality or safety)55(. The opacity will diminish gradually)55(. After removing over)-18(wrap, check for minute leaks by )]TJ
T*
[(squeezing inner bag firmly)55(. If leaks are found, discard solution as sterility may be impaired. )]TJ
0 -1.237 TD
[(DO NOT ADD SUPPLEMENT)55(AR)18(Y MEDICA)55(TION. )]TJ
/T1_2 1 Tf
0 -1.474 TD
(Preparation for )Tj
/Span<>> BDC
(A)Tj
EMC
(dministration:)Tj
/T1_0 1 Tf
0 -1.126 TD
(1.)Tj
/Span<>> BDC
( )Tj
EMC
1.231 0 Td
(Suspend container from eyelet support.)Tj
-1.231 -1.169 Td
(2.)Tj
/Span<>> BDC
( )Tj
EMC
1.231 0 Td
[(Remove plastic protector from outlet port at bottom of container)74(.)]TJ
-1.231 -1.169 Td
(3.)Tj
/Span<>> BDC
( )Tj
EMC
1.231 0 Td
(Attach administration set. Refer to complete directions accompanying set\
.)Tj
/T1_2 1 Tf
/Span<>> BDC
7.5 0 0 7.5 310.5 278.4108 Tm
(H)Tj
EMC
(OW SUPP)Tj
/Span<>> BDC
(L)Tj
EMC
(IED)Tj
/T1_0 1 Tf
6.5 0 0 6.5 310.5 271.0908 Tm
(Fluconazole Injections, USP: Fluconazole Injections, USP for intravenous\
infusion administration are formulated )Tj
0 -1.015 TD
[(as sterile iso-osmotic solutions containing 2 mg/mL of fluconazole. They\
are supplied in INTRA)37(VIA plastic )]TJ
0 -1.015 TD
(containers containing volumes of 100 mL or 200 mL affording doses of 200\
mg and 400 mg of fluconazole, )Tj
0 -1.015 TD
[(respectively)55(. )]TJ
0 -1.237 TD
[(Fluconazole Injections, USP in INTRA)37(VIA Plastic Containers:)]TJ
0 -1.188 TD
(2J1453)Tj
5.464 0 Td
(NDC 0069-0038-03)Tj
10.452 0 Td
(Fluconazole in Sodium Chloride Diluent)Tj
18.161 0 Td
(200 mg/100 mL x 10)Tj
-34.078 -1.216 Td
(2J1454)Tj
5.464 0 Td
(NDC 0069-0045-03)Tj
10.452 0 Td
(Fluconazole in Sodium Chloride Diluent)Tj
18.161 0 Td
(400 mg/200 mL x 10)Tj
/T1_2 1 Tf
-34.078 -1.391 Td
(Storage)Tj
/T1_0 1 Tf
0 -1.126 TD
(Store between 77\260F \(25\260C\) and 41\260F \(5\260C\). Brief exposure\
up to 104\260F \(40\260C\) does not adversely affect the )Tj
0 -1.015 TD
[(product. Protect from freezing. A)18(void excessive heat.)]TJ
/T1_2 1 Tf
0 -1.237 TD
(Rx only)Tj
7.5 0 0 7.5 310.5 185.9438 Tm
(REFERENCES)Tj
/T1_0 1 Tf
6.5 0 0 6.5 310.5 178.6238 Tm
(1.)Tj
/Span<>> BDC
( )Tj
EMC
4.431 0 Td
[(Clinical and Laborator)-18(y Standards Institute. Reference Method for Broth Dilution Antifungal )]TJ
0 -1.015 TD
[(Susceptibility T)74(esting of Y)55(easts; Approved Standard-Second Edition. CLSI Document M27-A2, 2002 )]TJ
0 -1.015 TD
[(V)18(olume 22, No 15, CLSI, W)18(ayne, P)37(A, August 2002.)]TJ
-4.431 -1.237 Td
(2.)Tj
/Span<>> BDC
( )Tj
EMC
4.431 0 Td
[(Clinical and Laborator)-18(y Standards Institute. Methods for Antifungal Disk Diffusion Susceptibil\
ity )]TJ
0 -1.015 TD
[(T)74(esting of Y)55(easts; Approved Guideline. CLSI Document M44-A, 2004 V)18(olume 24, No. 15 CLSI, )]TJ
0 -1.015 TD
[(W)18(ayne, P)37(A, May 2004.)]TJ
-4.431 -1.237 Td
(3.)Tj
/Span<>> BDC
( )Tj
EMC
4.431 0 Td
[(Pfaller)74(, M.A., Messer)74(, S.A., Boyken, L., Rice, C., T)74(endolkar)74(, S., Hollis, R.J., and Diekemal, D.J. Use )]TJ
T*
[(of Fluconazole as a Surrogate Marker T)74(o Predict Susceptibility and Resistance to V)18(oriconazole )]TJ
T*
[(among 13,338 Clinical Isolates of Candida spp. T)74(ested by Clinical and Laborator)-18(y Standard Institute-)]TJ
0 -1.015 TD
[(Recommended Broth Microdilution Methods. 2007. Journal of Clinical Micro\
biology)55(. 45:70-75.)]TJ
21.415 -10.352 Td
(Maalox\256 is a registered trademark of )Tj
T*
[(A)18(ventis Pharmaceuticals Products Inc. )]TJ
0 -1.237 TD
(Baxter and Intravia are registered trademarks )Tj
0 -1.015 TD
(of Baxter International Inc.)Tj
/T1_2 1 Tf
-25.692 3.268 Td
(Baxter )Tj
/Span<>> BDC
(H)Tj
EMC
(ealthcare Corporation)Tj
/T1_0 1 Tf
( )Tj
T*
[(Deer)-20(field, IL 60015 USA)]TJ
0 -1.015 TD
(Printed in USA)Tj
/T1_2 1 Tf
0 -1.237 TD
(07-19-66-173)Tj
/Span<>> BDC
[( )211( )]TJ
EMC
11.077 0 Td
[(Rev)55(. )]TJ
/Span<>> BDC
(A)Tj
EMC
(ugust 2010)Tj
/T1_0 1 Tf
-11.077 8.954 Td
(Distributed By)Tj
0 -1.237 TD
(Pfizer Labs)Tj
0 -1.237 TD
(Division of Pfizer Inc)Tj
0 -1.237 TD
[(New Y)55(ork, NY 10017)]TJ
ET
/PlacedGraphic /MC0 BDC
EMC
q
311.5 94.176 60.839 13.464 re
W n
q 1 0 0 1 341.1724 103.268 cm
0 0 m
-0.024 -0.12 -0.083 -0.157 -0.184 -0.157 c
-0.61 -0.157 l
-1.293 -4.05 l
-0.891 -4.05 l
-0.787 -4.05 -0.752 -4.115 -0.766 -4.205 c
-0.817 -4.524 l
-0.832 -4.613 -0.885 -4.671 -0.982 -4.671 c
-2.749 -4.671 l
-2.847 -4.671 -2.891 -4.613 -2.875 -4.532 c
-2.816 -4.198 l
-2.793 -4.095 -2.74 -4.05 -2.637 -4.05 c
-2.242 -4.05 l
-1.56 -0.157 l
-1.993 -0.157 l
-2.095 -0.157 -2.125 -0.106 -2.11 -0.009 c
-2.059 0.318 l
-2.044 0.399 -1.983 0.466 -1.894 0.466 c
-0.075 0.466 l
0.029 0.466 0.073 0.399 0.06 0.326 c
h
f
Q
q 1 0 0 1 344.4927 100.7786 cm
0 0 m
-0.357 -1.993 l
-0.378 -2.119 -0.431 -2.183 -0.564 -2.183 c
-1.1 -2.183 l
-1.264 -2.183 -1.271 -2.102 -1.248 -1.993 c
-0.891 0.03 l
-0.875 0.126 -0.862 0.245 -0.862 0.327 c
-0.862 0.594 -0.98 0.728 -1.331 0.728 c
-1.621 0.728 -2.004 0.572 -2.273 0.372 c
-2.69 -1.997 l
-2.712 -2.123 -2.773 -2.183 -2.898 -2.183 c
-3.438 -2.183 l
-3.58 -2.183 -3.605 -2.108 -3.59 -2.005 c
-3.017 1.233 l
-2.995 1.352 -2.935 1.419 -2.803 1.419 c
-2.316 1.419 l
-2.206 1.419 -2.146 1.382 -2.164 1.277 c
-2.194 1.085 l
-1.805 1.359 -1.339 1.515 -0.905 1.515 c
-0.215 1.515 0.06 1.136 0.06 0.527 c
0.06 0.423 0.022 0.143 0 0 c
f
Q
q 1 0 0 1 345.9563 102.6661 cm
0 0 m
-0.222 0 -0.425 0.14 -0.425 0.378 c
-0.425 0.691 -0.134 0.943 0.17 0.943 c
0.4 0.943 0.594 0.793 0.594 0.556 c
0.594 0.244 0.305 0 0 0 c
0.184 -0.469 m
0.325 -0.461 0.342 -0.536 0.325 -0.633 c
-0.244 -3.902 l
-0.364 -4.577 -0.596 -5.065 -0.997 -5.363 c
-1.285 -5.579 -1.636 -5.69 -2.139 -5.69 c
-2.28 -5.69 -2.453 -5.667 -2.624 -5.639 c
-2.696 -5.624 -2.725 -5.587 -2.725 -5.534 c
-2.725 -5.511 -2.72 -5.483 -2.712 -5.453 c
-2.563 -5.038 l
-2.541 -4.978 -2.511 -4.941 -2.453 -4.941 c
-2.431 -4.941 l
-2.362 -4.948 -2.295 -4.963 -2.228 -4.963 c
-1.886 -4.963 -1.539 -4.843 -1.373 -4.599 c
-1.285 -4.466 -1.211 -4.271 -1.166 -4.027 c
-0.572 -0.633 l
-0.551 -0.522 -0.47 -0.469 -0.364 -0.469 c
h
f
Q
q 1 0 0 1 348.5323 101.6027 cm
0 0 m
-0.476 0 -0.883 -0.439 -1.002 -0.825 c
0.506 -0.825 l
0.52 -0.751 0.528 -0.669 0.528 -0.594 c
0.528 -0.238 0.401 0 0 0 c
1.324 -1.22 m
1.295 -1.395 1.226 -1.411 1.04 -1.411 c
-1.127 -1.411 l
-1.127 -1.441 -1.137 -1.493 -1.137 -1.536 c
-1.137 -2.072 -0.802 -2.376 -0.259 -2.376 c
0.05 -2.376 0.395 -2.309 0.698 -2.199 c
0.783 -2.169 0.863 -2.147 0.877 -2.265 c
0.913 -2.676 l
0.922 -2.777 0.877 -2.816 0.773 -2.859 c
0.379 -3.016 -0.089 -3.097 -0.476 -3.097 c
-1.478 -3.097 -2.079 -2.547 -2.079 -1.656 c
-2.079 -0.365 -1.196 0.69 0.119 0.69 c
0.922 0.69 1.391 0.215 1.391 -0.556 c
1.391 -0.706 1.353 -1.062 1.324 -1.22 c
f
Q
q 1 0 0 1 353.3477 101.8999 cm
0 0 m
-0.173 -0.401 l
-0.201 -0.477 -0.226 -0.506 -0.27 -0.506 c
-0.29 -0.506 -0.322 -0.491 -0.357 -0.477 c
-0.579 -0.37 -0.758 -0.312 -0.975 -0.312 c
-1.79 -0.312 -2.288 -1.07 -2.288 -1.834 c
-2.288 -2.346 -2.044 -2.693 -1.515 -2.693 c
-1.198 -2.693 -0.997 -2.636 -0.714 -2.533 c
-0.693 -2.526 -0.662 -2.518 -0.641 -2.518 c
-0.597 -2.518 -0.567 -2.541 -0.558 -2.6 c
-0.491 -2.949 l
-0.491 -2.964 -0.485 -2.987 -0.485 -2.999 c
-0.485 -3.074 -0.529 -3.112 -0.648 -3.164 c
-1.018 -3.32 -1.382 -3.395 -1.76 -3.395 c
-2.727 -3.395 -3.233 -2.837 -3.233 -1.967 c
-3.233 -0.698 -2.334 0.393 -1.003 0.393 c
-0.669 0.393 -0.329 0.327 -0.046 0.185 c
0.007 0.155 0.027 0.134 0.027 0.095 c
0.027 0.066 0.012 0.037 0 0 c
f
Q
q 1 0 0 1 355.9625 101.7213 cm
0 0 m
-0.016 -0.089 -0.083 -0.142 -0.173 -0.142 c
-1.005 -0.142 l
-1.289 -1.74 l
-1.331 -1.984 -1.339 -2.08 -1.339 -2.183 c
-1.339 -2.428 -1.22 -2.502 -0.973 -2.502 c
-0.802 -2.502 -0.649 -2.457 -0.484 -2.413 c
-0.461 -2.408 -0.44 -2.399 -0.41 -2.399 c
-0.357 -2.399 -0.329 -2.436 -0.329 -2.489 c
-0.32 -2.896 l
-0.32 -2.904 l
-0.32 -2.956 -0.342 -3.008 -0.416 -3.039 c
-0.737 -3.164 -1.035 -3.216 -1.316 -3.216 c
-1.836 -3.216 -2.275 -2.971 -2.275 -2.391 c
-2.275 -2.183 -2.237 -2.014 -2.201 -1.798 c
-1.906 -0.142 l
-2.26 -0.142 l
-2.334 -0.142 -2.423 -0.104 -2.409 -0.014 c
-2.339 0.326 l
-2.326 0.416 -2.275 0.476 -2.178 0.476 c
-1.798 0.476 l
-1.652 1.284 l
-1.629 1.41 -1.553 1.449 -1.434 1.464 c
-1.28 1.485 -1.021 1.53 -0.878 1.53 c
-0.753 1.53 -0.723 1.485 -0.743 1.367 c
-0.901 0.476 l
-0.063 0.476 l
0.004 0.476 0.072 0.423 0.059 0.349 c
h
f
Q
q 1 0 0 1 358.8133 101.4391 cm
0 0 m
-0.127 0.051 -0.305 0.119 -0.586 0.119 c
-0.875 0.119 -1.159 -0.016 -1.329 -0.202 c
-1.641 -0.528 -1.797 -1.04 -1.797 -1.448 c
-1.797 -1.871 -1.597 -2.198 -1.172 -2.198 c
-0.808 -2.198 -0.453 -1.925 -0.305 -1.695 c
h
1.168 -2.131 m
1.106 -2.495 l
1.093 -2.585 1.025 -2.675 0.941 -2.719 c
0.853 -2.762 0.573 -2.912 0.218 -2.912 c
-0.17 -2.912 -0.305 -2.658 -0.314 -2.409 c
-0.328 -2.409 l
-0.608 -2.732 -1.041 -2.934 -1.456 -2.934 c
-2.344 -2.934 -2.743 -2.243 -2.743 -1.5 c
-2.743 -0.854 -2.475 -0.177 -2.012 0.29 c
-1.665 0.638 -1.138 0.854 -0.608 0.854 c
-0.127 0.854 0.342 0.742 0.84 0.521 c
0.937 0.476 0.98 0.432 0.959 0.319 c
0.573 -1.849 l
0.556 -1.925 0.551 -1.999 0.551 -2.05 c
0.551 -2.139 0.594 -2.19 0.668 -2.19 c
0.795 -2.19 0.959 -2.124 1.062 -2.065 c
1.078 -2.057 1.093 -2.05 1.106 -2.05 c
1.142 -2.05 1.168 -2.08 1.168 -2.117 c
h
f
Q
q 1 0 0 1 362.5433 101.5359 cm
0 0 m
-0.276 0 -0.633 -0.147 -0.862 -0.334 c
-1.197 -2.183 l
-1.062 -2.236 -0.871 -2.286 -0.646 -2.286 c
0.192 -2.286 0.6 -1.389 0.6 -0.669 c
0.6 -0.29 0.416 0 0 0 c
-0.706 -3.031 m
-1.228 -3.031 -1.776 -2.881 -2.022 -2.809 c
-2.135 -2.772 -2.179 -2.666 -2.155 -2.54 c
-1.34 2.089 l
-1.314 2.206 -1.272 2.273 -1.153 2.288 c
-0.515 2.369 l
-0.401 2.384 -0.394 2.303 -0.408 2.222 c
-0.738 0.393 l
-0.47 0.601 -0.089 0.757 0.297 0.757 c
1.106 0.757 1.543 0.186 1.543 -0.549 c
1.543 -1.903 0.733 -3.031 -0.706 -3.031 c
f
Q
q 1 0 0 1 365.8549 103.8979 cm
0 0 m
0.121 0.006 0.128 -0.073 0.112 -0.157 c
-0.765 -5.117 l
-0.787 -5.243 -0.854 -5.303 -0.957 -5.303 c
-1.521 -5.303 l
-1.611 -5.303 -1.671 -5.259 -1.671 -5.17 c
-1.671 -5.154 -1.663 -5.14 -1.663 -5.124 c
-0.802 -0.253 l
-0.78 -0.126 -0.727 -0.089 -0.623 -0.073 c
h
f
Q
q 1 0 0 1 367.8904 101.6027 cm
0 0 m
-0.476 0 -0.883 -0.439 -1.002 -0.825 c
0.504 -0.825 l
0.519 -0.751 0.528 -0.669 0.528 -0.594 c
0.528 -0.238 0.402 0 0 0 c
1.322 -1.22 m
1.292 -1.395 1.226 -1.411 1.04 -1.411 c
-1.128 -1.411 l
-1.128 -1.441 -1.137 -1.493 -1.137 -1.536 c
-1.137 -2.072 -0.802 -2.376 -0.258 -2.376 c
0.054 -2.376 0.395 -2.309 0.698 -2.199 c
0.78 -2.169 0.862 -2.147 0.877 -2.265 c
0.913 -2.676 l
0.923 -2.777 0.877 -2.816 0.774 -2.859 c
0.378 -3.016 -0.09 -3.097 -0.476 -3.097 c
-1.478 -3.097 -2.079 -2.547 -2.079 -1.656 c
-2.079 -0.365 -1.196 0.69 0.119 0.69 c
0.923 0.69 1.388 0.215 1.388 -0.556 c
1.388 -0.706 1.354 -1.062 1.322 -1.22 c
f
Q
q 1 0 0 1 372.3103 101.8911 cm
0 0 m
-0.165 -0.4 l
-0.188 -0.452 -0.232 -0.481 -0.284 -0.481 c
-0.307 -0.481 -0.334 -0.475 -0.356 -0.468 c
-0.604 -0.372 -0.885 -0.288 -1.149 -0.288 c
-1.389 -0.288 -1.688 -0.414 -1.688 -0.697 c
-1.688 -0.928 -1.369 -1.024 -1.025 -1.165 c
-0.634 -1.329 -0.209 -1.536 -0.209 -2.057 c
-0.209 -2.39 -0.379 -2.723 -0.618 -2.947 c
-0.938 -3.243 -1.397 -3.386 -1.865 -3.386 c
-2.184 -3.386 -2.659 -3.281 -2.934 -3.127 c
-2.971 -3.104 -3.001 -3.081 -3.001 -3.029 c
-3.001 -2.999 -2.986 -2.97 -2.971 -2.94 c
-2.817 -2.562 l
-2.795 -2.509 -2.757 -2.457 -2.697 -2.457 c
-2.667 -2.457 -2.645 -2.464 -2.614 -2.472 c
-2.324 -2.591 -2.044 -2.702 -1.725 -2.702 c
-1.441 -2.702 -1.099 -2.576 -1.099 -2.241 c
-1.099 -1.976 -1.457 -1.878 -1.821 -1.736 c
-2.214 -1.581 -2.622 -1.372 -2.622 -0.838 c
-2.622 -0.02 -1.798 0.402 -1.078 0.402 c
-0.744 0.402 -0.334 0.342 -0.038 0.179 c
0 0.157 0.029 0.134 0.029 0.091 c
0.029 0.06 0.014 0.031 0 0 c
f
Q
q 1 0 0 1 334.6604 102.5857 cm
0 0 m
-0.003 -3.278 -4.494 -6.749 -10.361 -7.973 c
-11.768 -8.267 -13.143 -8.408 -14.441 -8.41 c
-15.114 -8.412 -15.767 -8.375 -16.391 -8.304 c
-14.462 -0.881 l
-13.254 -0.881 l
-14.099 -4.033 l
-12.866 -4.033 l
-12.715 -3.47 -12.175 -1.418 -11.857 -0.262 c
-14.296 -0.262 l
-13.927 1.175 l
-13.854 1.449 -13.795 1.609 -13.749 1.729 c
-13.547 2.243 -13.237 2.539 -12.865 2.596 c
-12.565 2.644 -12.455 2.455 -12.453 2.335 c
-12.451 2.101 -12.64 2.051 -12.637 1.734 c
-12.635 1.501 -12.483 1.147 -12.001 1.147 c
-11.532 1.147 -11.237 1.468 -11.213 1.95 c
-11.203 2.183 -11.246 2.439 -11.595 2.683 c
-11.963 2.941 -12.622 2.997 -13.064 2.957 c
-13.878 2.883 -14.458 2.378 -14.821 1.766 c
-15.099 1.292 -15.256 0.872 -15.537 -0.215 c
-16.969 -5.715 -17.592 -8.119 v
-20.539 -7.532 -22.661 -6.091 -23.084 -4.06 c
-23.136 -3.813 -23.16 -3.564 -23.16 -3.314 c
-23.159 -0.045 -18.842 3.393 -12.988 4.614 c
-11.559 4.912 -10.151 5.054 -8.819 5.054 c
-4.281 5.054 -0.634 3.411 -0.073 0.723 c
-0.024 0.484 0 0.243 0 0 c
-5.413 -2.858 m
-5.477 -2.922 -6.023 -3.452 -6.6 -3.452 c
-7.031 -3.452 -7.34 -3.142 -7.34 -2.778 c
-7.34 -2.701 -7.346 -2.645 -7.33 -2.502 c
-6.65 -2.502 -6.245 -2.423 -5.843 -2.288 c
-5.199 -2.079 -4.772 -1.528 -4.772 -0.993 c
-4.772 -0.476 -5.336 -0.172 -5.988 -0.172 c
-7.302 -0.172 -8.529 -1.336 -8.529 -2.701 c
-8.529 -3.571 -7.894 -4.157 -6.956 -4.157 c
-6.523 -4.157 -6.128 -4.06 -5.783 -3.881 c
-5.564 -3.767 -5.37 -3.612 -5.199 -3.432 c
h
-6.074 -1.671 m
-6.365 -1.899 -6.681 -1.984 -7.242 -2.003 c
-7.151 -1.587 -6.913 -1.215 -6.605 -0.978 c
-6.422 -0.837 -6.199 -0.765 -6.061 -0.765 c
-5.76 -0.765 -5.693 -0.933 -5.693 -1.04 c
-5.693 -1.234 -5.812 -1.466 -6.074 -1.671 c
-8.212 -0.262 m
-11.297 -0.262 l
-11.464 -0.881 l
-9.743 -0.881 l
-10.122 -1.465 -12.115 -2.841 -12.115 -4.033 c
-8.958 -4.033 l
-8.754 -3.274 l
-10.698 -3.274 l
-10.238 -2.387 -8.566 -1.434 -8.212 -0.262 c
-1.654 -0.198 m
-2.14 -0.198 -2.67 -0.676 -2.953 -1.018 c
-2.737 -0.262 l
-3.941 -0.262 l
-4.958 -4.033 l
-3.719 -4.033 l
-3.238 -2.273 l
-3.202 -2.148 -3.139 -1.971 -3.055 -1.787 c
-2.93 -1.517 -2.761 -1.238 -2.562 -1.061 c
-2.414 -0.93 -2.273 -0.861 -2.1 -0.888 c
-1.979 -0.907 -1.945 -1.009 -1.93 -1.113 c
-1.918 -1.202 -1.901 -1.309 -1.796 -1.414 c
-1.757 -1.455 -1.656 -1.546 -1.43 -1.546 c
-1.129 -1.546 -0.868 -1.291 -0.868 -0.92 c
-0.868 -0.605 -0.97 -0.198 -1.654 -0.198 c
-17.33 -0.273 m
-17.634 -1.246 -18.252 -1.417 -19.235 -1.419 c
-18.993 -0.528 -18.743 0.399 -18.565 1.057 c
-18.349 1.057 l
-17.179 1.057 -17.083 0.524 -17.33 -0.273 c
-18.211 1.619 m
-19.652 1.619 l
-20.954 -3.194 -21.182 -4.033 v
-19.942 -4.033 l
-19.864 -3.746 -19.648 -2.946 -19.396 -2.021 c
-16.859 -2.016 -16.263 -1.307 -16.031 -0.313 c
-15.844 0.491 -16.001 1.619 -18.211 1.619 c
f
Q
Q
endstream
endobj
24 0 obj
<>stream
application/postscript
Basic CMYK
2011-07-07T11:03:07-05:00
2011-07-07T11:03:07-05:00
2011-07-07T11:03:07-05:00
Adobe Illustrator CS5
256
60
JPEG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xmp.iid:FD7F1174072068118083C8347657A29B
xmp.did:FD7F1174072068118083C8347657A29B
uuid:5B20892493BFDB11914A8590D31508C8
proof:pdf
xmp.iid:F77F1174072068118F62EE0737E0B01C
xmp.did:F77F1174072068118F62EE0737E0B01C
uuid:5B20892493BFDB11914A8590D31508C8
proof:pdf
converted
from application/pdf to <unknown>
saved
xmp.iid:CF7F11740720681191099C3B601C4548
2008-04-17T14:19:07+05:30
Adobe Illustrator CS4
/
converted
from application/pdf to <unknown>
converted
from application/pdf to <unknown>
saved
xmp.iid:0080117407206811BDDDFD38D0CF24DD
2008-05-16T12:18:29-07:00
Adobe Illustrator CS4
/
converted
from application/vnd.adobe.illustrator to application/vnd.adobe.illustrator
saved
xmp.iid:F87F117407206811B628E3BF27C8C41B
2008-05-22T12:59:33-07:00
Adobe Illustrator CS4
/
converted
from application/vnd.adobe.illustrator to application/vnd.adobe.illustrator
saved
xmp.iid:0BC3BD25102DDD1181B594070CEB88D9
2008-05-28T17:02:32-07:00
Adobe Illustrator CS4
/
saved
xmp.iid:F87F117407206811BB1DBF8F242B6F84
2008-06-09T15:05:10-07:00
Adobe Illustrator CS4
/
saved
xmp.iid:F97F117407206811BB1DBF8F242B6F84
2008-06-09T15:05:47-07:00
Adobe Illustrator CS4
/
saved
xmp.iid:F77F117407206811ACAFB8DA80854E76
2008-06-11T14:30:01-07:00
Adobe Illustrator CS4
/
saved
xmp.iid:F77F1174072068118F62EE0737E0B01C
2011-04-21T07:52:28-04:00
Adobe Illustrator CS4
/
converted
from application/postscript to application/vnd.adobe.illustrator
saved
xmp.iid:FD7F1174072068118083C8347657A29B
2011-07-07T11:03:07-05:00
Adobe Illustrator CS5
/
Basic CMYK
False
False
1
8.500000
11.000000
Inches
PANTONE 287 C
Default Swatch Group
0
White
CMYK
PROCESS
0.000000
0.000000
0.000000
0.000000
Black
CMYK
PROCESS
0.000000
0.000000
0.000000
100.000000
PANTONE 287 C
SPOT
100.000000
CMYK
100.000000
68.000000
0.000000
12.000000
Adobe PDF library 9.00
endstream
endobj
16 0 obj
<>
endobj
17 0 obj
<>
endobj
15 0 obj
<>
endobj
31 0 obj
<>
endobj
32 0 obj
<>stream
H\͊@OQEcuo7H tCdV2DŘE~x!@o}ی.>t!Դm;sf˕jKgyZ|_xٷ.+
H7pw;,6qhڳ{=
^.m%ޥUe r
endstream
endobj
33 0 obj
<>stream
HDT
TW$df$~L43(U*EDP(*+F2@Hv!$&V?ӮⱢ֢=bYz9+z;nfϾ㳳aMܰL7|N&ZSRfm!_RgZl*X*}/YTo)xhJB§X*K"I0ӣxaS~IX)T%|db(,3&LzRŧ7כ|(-B ,6=7TXV1f4o,%l\6R-dhT,%rhY*&O)["#ij'HNX+~~~=4eRT> >jLӳ#?JU}0;2Ȕ*ufx
<,ő=(~?C4P"$M^*Iީ=m=Qp8ӴQ4y<9TmSNWs։1GíI^u˒oqyG\.{gb3>q}
(Grڊ P3jE
p_NHTCz*3 Ճ3H AS6^'Z+9z]RQ-4!>dC0=]G& &)+=O!3k3?XI#'7a.n5g ㏤% G(g/
ï~=
FN*](!CS aGn9Hezպ&K_0sZAzѵ7ӾR040&e|,9r
6M 1t(l-9ױ&r"Py_e4"iu
2@h85 2yA<{PŕerИ(`|ntХQE*cơ2%C=g
ER5*){Zl'xf ? w6mgf`mI{Nh~c\HB̗OvT6Q2l0r-0C +rXp dYDX%fn&@SQ
[!,oP?b gL>0Sג̦t;&:.|a6R{ǎ'eq,^ʍ[2ϓ<Р)W A<fֽ{5,84ny_놡Iʠ,y'[ob whXHhѬՓQVRkQ 솆S(D [7sX}bK r|xK
,M`r\%ga%X{DԦS8d%({$JU>s9{OhE.42 _Vt؈G.>똍d^,l~/\eҖ#r)FNv;vs47kEo(e^<ǹbkfF߁H=Gwu_tr/բW5>U@r"uhkYS(%j؟]@] yv>}G0*4}ơ:ЪYô/`srv`ʿM
(JGS?MEtk?UřBq k&&*%BBʡ
(#503"* ;#&niǪ}=kw|b/曏D`6mYx%iP
P\Oٲײ`m^沔lN$(>5RZzRDdcŭccټ;WGQg]w[.}si*$g3֔4o xS77|~`xjF1]eWD&#ǥ` $ډ35{%k~Lj8)BQ>0ExZ
dEEC6Ӵ0- L}i{O[#KiqH ɬy IǨ{zwxSG2/WAk0]-yV#1`0R~G2>B
y08GX50:ƌFU?c=LX@zL?/XPg$EU
3-qZ)@[Ta͘4cF֑
]sO7:OU^P